Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis
Background Lp(a) (lipoprotein(a)) is an independent risk factor for calcific aortic valve stenosis (CAVS). Whether patients with CAVS and high Lp(a) levels are at higher risk of valvular or cardiovascular events is unknown. The aim of this study is to determine whether higher Lp(a) levels are associ...
Saved in:
| Main Authors: | Arnaud S. Girard, Audrey Paulin, Hasanga D. Manikpurage, Emma Lajeunesse, Marie‐Annick Clavel, Philippe Pibarot, John H. Krege, Patrick Mathieu, Sébastien Thériault, Benoit J. Arsenault |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.038955 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of lipoprotein(a) and LPA gene with calcific aortic valve disease
by: Xinyi Yu, et al.
Published: (2025-08-01) -
Grading of Aortic Valve Calcification Severity and Risk Stratification in Aortic Stenosis
by: Lionel Tastet, et al.
Published: (2024-08-01) -
Aortic valve-specific genes dysregulated in calcific aortic valve stenosis as potential biomarkers and therapeutic targets
by: Pardis Zamani, et al.
Published: (2025-07-01) -
Conjugated bile acids are elevated in severe calcific aortic valve stenosis
by: Hannah Zhang, et al.
Published: (2025-06-01) -
<sup>18</sup>F-sodium fluoride and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for assessment of aortic valve inflammation and calcification in patients with aortic stenosis
by: P. M. Murtazalieva, et al.
Published: (2019-12-01)